[18F]MK‐9470 PET measurement of cannabinoid CB1 receptor availability in chronic cannabis users

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Addiction Biology

• Publication date

  2015-03-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1111/adb.12116PMID 24373053
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dr. Gilberto Gerra, Chief of Drug Prevention and Health Branch, Division for Operations, United Nations Office on Drugs and Crime (UNODC), Vienna.

  2013cited by this paper
• Reduced cannabinoid CB 1 receptor binding in alcohol dependence measured with positron emission tomography

  2013influential reference
• Transient changes in the endocannabinoid system after acute and chronic ethanol exposure and abstinence in the rat: a combined PET and microdialysis study

  2013influential reference
• Reduced cannabinoid CB1 receptor binding in alcohol dependence measured with positron emission tomography

  2013cited by this paper
• Increased ventral striatal CB1 receptor binding is related to negative symptoms in drug-free patients with schizophrenia

  2013influential reference
• Synaptic targets of Δ9-tetrahydrocannabinol in the central nervous system.

  2013influential reference
• Regional changes in type 1 cannabinoid receptor availability in Parkinson's disease in vivo.

  2012influential reference
• Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers

  2012influential reference
• Brain type 1 cannabinoid receptor availability in patients with anorexia and bulimia nervosa.

  2011influential reference
• Pharmacological treatment of cannabis dependence.

  2011influential reference
• Widespread Decrease of Type 1 Cannabinoid Receptor Availability in Huntington Disease In Vivo

  2010influential reference
• International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2

  2010influential reference
• Influence of Chronic Nicotine Administration on Cerebral Type 1 Cannabinoid Receptor Binding: An In Vivo Micro-PET Study in the Rat Using [18F]MK-9470

  2010cited by this paper
• Erratum to: Kinetic analysis of the cannabinoid-1 receptor PET tracer [18F]MK-9470 in human brain

  2010cited by this paper
• Kinetic analysis of the cannabinoid-1 receptor PET tracer [18F]MK-9470 in human brain

  2010influential reference
• Relationship of type 1 cannabinoid receptor availability in the human brain to novelty-seeking temperament.

  2009influential reference
• The endocannabinoid system as a target for the treatment of cannabis dependence.

  2009cited by this paper
• Inhibitors of Endocannabinoid-Metabolizing Enzymes Reduce Precipitated Withdrawal Responses in THC-Dependent Mice

  2009cited by this paper
• Adverse health effects of non-medical cannabis use.

  2009cited by this paper
• Changes in cerebral type 1 cannabinoid receptor (CB1R) availability in ethanol-dependent patients after binge drinking and abstinence

  2009cited by this paper
• Gene-environment interplay between cannabis and psychosis.

  2008cited by this paper
• Gender-dependent increases with healthy aging of the human cerebral cannabinoid-type 1 receptor binding using [18F]MK-9470 PET

  2008influential reference
• Positron emission tomography imaging using an inverse agonist radioligand to assess cannabinoid CB1 receptors in rodents

  2008cited by this paper
• Cannabis reinforcement and dependence: role of the cannabinoid CB1 receptor

  2008influential reference
• [18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor

  2007influential reference
• Single and multiple doses of rimonabant antagonize acute effects of smoked cannabis in male cannabis users

  2007cited by this paper
• Cannabis, the mind and society: the hash realities

  2007influential reference
• Chronic use of marijuana decreases cannabinoid receptor binding and mRNA expression in the human brain.

  2007cited by this paper
• A Weight Index for the Standardized Uptake Value in 2-Deoxy-2-[F-18]fluoro-d-glucose-Positron Emission Tomography

  2007cited by this paper
• Two Brain Sites for Cannabinoid Reward

  2006influential reference
• Prolonged Recovery Rate of CB1 Receptor Adaptation after Cessation of Long-Term Cannabinoid Administration

  2006cited by this paper
• Metabolic imaging of anterior capsular stimulation in refractory obsessive-compulsive disorder: a key role for the subgenual anterior cingulate and ventral striatum.

  2006cited by this paper
• Cannabinoid tolerance and dependence: a review of studies in laboratory animals.

  2005cited by this paper
• Signaling pathways involved in the development of cannabinoid tolerance.

  2004cited by this paper
• Δ9-Tetrahydrocannabinol-induced conditioned place preference and intracerebroventricular self-administration in rats

  2004influential reference
• Delta9-tetrahydrocannabinol-induced conditioned place preference and intracerebroventricular self-administration in rats.

  2004cited by this paper
• Cannabis and the brain.

  2003cited by this paper
• Functional Tolerance and Blockade of Long-Term Depression at Synapses in the Nucleus Accumbens after Chronic Cannabinoid Exposure

  2003cited by this paper
• The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders.

  2003cited by this paper
• The effects of delta9-tetrahydrocannabinol physical dependence on brain cannabinoid receptors.

  2003cited by this paper
• Brain circuitry and the reinstatement of cocaine-seeking behavior

  2003cited by this paper
• Regulation of cannabinoid CB1 receptors in the central nervous system by chronic cannabinoids.

  2003cited by this paper
• Endocannabinoid Signaling in the Brain

  2002cited by this paper
• Study of cannabinoid dependence in animals.

  2002cited by this paper
• Effect of Chronic Administration ofR-(+)-[2,3-Dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone Mesylate (WIN55,212-2) or Δ9-Tetrahydrocannabinol on Cannabinoid Receptor Adaptation in Mice

  2002influential reference
• Chronic delta9-tetrahydrocannabinol treatment produces a time-dependent loss of cannabinoid receptors and cannabinoid receptor-activated G proteins in rat brain.

  1999cited by this paper
• Society for the study of addiction.

  1999cited by this paper
• Chronic ▵9‐Tetrahydrocannabinol Treatment Produces a Time‐Dependent Loss of Cannabinoid Receptors and Cannabinoid Receptor‐Activated G Proteins in Rat Brain

  1999influential reference
• World drug report

  1998cited by this paper
• Time‐course of the cannabinoid receptor down‐regulation in the adult rat brain caused by repeated exposure to Δ9‐tetrahydrocannabinol

  1998cited by this paper
• Effects of chronic exposure to Δ9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions

  1997influential reference
• Effects of chronic exposure to delta9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions.

  1997influential reference
• Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain.

  1997cited by this paper
• Effects of chronic treatment with delta9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgammaS autoradiography in rat brain.

  1996influential reference
• Effects of Chronic Treatment with Δ9-Tetrahydrocannabinol on Cannabinoid-Stimulated [35S]GTPγS Autoradiography in Rat Brain

  1996influential reference
• Downregulation of rat brain cannabinoid binding sites after chronic delta 9-tetrahydrocannabinol treatment.

  1994cited by this paper
• Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study.

  1993cited by this paper
• CAN SOCIAL INTERACTION BE USED TO MEASURE ANXIETY?

  1978cited by this paper
• Society for the Study of Addiction

  1977cited by this paper
• Marihuana chemistry.

  1970cited by this paper

• CBD and the 5-HT1A receptor: A medicinal and pharmacological review.

  2025cites this paper
• Regular cannabis use modulates gamma functional connectivity with V1 during visual processing

  2025cites this paper
• Functional Neuroimaging in Clinical Neurology: A Comprehensive Review of Commonly Used Modalities

  2025cites this paper
• Cannabis perturbs dynamic brain states.

  2025cites this paper
• PET Molecular Imaging of the Endocannabinoid System in Psychiatric Disorders

  2025cites this paper
• Pharmacotherapy for Cannabis Use Disorder: Preclinical and Clinical Models.

  2025cites this paper
• A preliminary investigation of tobacco co-use on endocannabinoid activity in people with cannabis use

  2025cites this paper
• The Role of Fatty Acid Binding Proteins in Neuropsychiatric Diseases: A Narrative Review.

  2025cites this paper
• PET Imaging in Psychiatric Disorders.

  2025cites this paper
• Receptor-enriched analysis of functional connectivity (REACT) for understanding cannabinoid neuropsychopharmacology

  2025cites this paper
• Cannabinoid CB1 receptor-sensitive neurodevelopmental processes and trajectories

  2025cites this paper
• Longer chronic cannabis use in humans is associated with impaired implicit motor learning and supranormal resting state cortical activity

  2025cites this paper
• Cannabis use and suicide in people with a diagnosis of schizophrenia: a systematic review and meta-analysis of longitudinal, case control, and cross-sectional studies

  2025influential citation
• Cannabinoid-based Pharmacology for the Management of Substance Use Disorders.

  2025cites this paper
• Effect of Cannabis Usage on Thyroid Eye Disease

  2024cites this paper
• Multimodal examination of daily stress rhythms in chronic Cannabis users

  2024cites this paper
• Cannabis use disorder: from neurobiology to treatment

  2024cites this paper
• Abnormal developmental of hippocampal subfields and amygdalar subnuclei volumes in young adults with heavy cannabis use: A three-year longitudinal study.

  2024cites this paper
• Endocannabinoid signaling in stress, nausea, and vomiting

  2024cites this paper
• Fatty Acid Amide Hydrolase and Cannabinoid Receptor Type 1 Genes Regulation is Modulated by Social Isolation in Rats

  2024cites this paper
• CANNABIS USE AND SUICIDE IN NON-AFFECTIVE PSYCHOSIS: A MINI-REVIEW OF RECENT LITERATURE.

  2023cites this paper
• Empathy‐related differences in the anterior cingulate functional connectivity of regular cannabis users when compared to controls

  2023cites this paper
• Circulating Endocannabinoids and N-Acylethanolamines in Individuals with Cannabis Use Disorder—Preliminary Findings

  2023influential citation
• The endocannabinoid system as a putative target for the development of novel drugs for the treatment of psychiatric illnesses

  2023cites this paper
• Sex differences in neuroendocrine, sympathetic nervous system, and affect responses to acute stress in cannabis users

  2023cites this paper
• Mechanisms of cannabinoid tolerance.

  2023cites this paper
• Molecular brain differences and cannabis involvement: A systematic review of positron emission tomography studies.

  2023cites this paper
• The Inflammatory Signals Associated with Psychosis: Impact of Comorbid Drug Abuse

  2023cites this paper
• Cannabis use is associated with low plasma endocannabinoid Anandamide in individuals with psychosis

  2023cites this paper
• Beyond monoamines: II. Novel applications for PET imaging in psychiatric disorders

  2022influential citation
• Alcohol-Endocannabinoid Interactions: Implications for Addiction-Related Behavioral Processes

  2022cites this paper
• Impact of cyclooxygenase‐2 inhibition on cannabis withdrawal and circulating endocannabinoids in daily cannabis smokers

  2022cites this paper
• Molecular Alterations of the Endocannabinoid System in Psychiatric Disorders

  2022influential citation
• The Relationship Between Circulating Endogenous Cannabinoids and the Effects of Smoked Cannabis

  2022cites this paper
• Cannabinoid receptor availability modulates the magnitude of dopamine release in vivo in the human reward system: A preliminary multitracer positron emission tomography study

  2022cites this paper
• Cannabis Use and Neuroadaptation: A Call for Δ9-Tetrahydrocannabinol Challenge Studies

  2022cites this paper
• The Endocannabinoid System as a Biomarker for Diagnostic and Therapeutic Applications in Depression and Anxiety.

  2022cites this paper
• Investigating the “two-hit hypothesis”: effects of prenatal maternal immune activation and adolescent cannabis use on neurodevelopment in mice

  2022cites this paper
• Biomarkers of the Endocannabinoid System in Substance Use Disorders

  2022cites this paper
• Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Plasma Endocannabinoid Levels in Healthy Volunteers: A Randomized Double-Blind Four-Arm Crossover Study

  2022cites this paper
• Synaptic changes induced by cannabinoid drugs and cannabis use disorder

  2022cites this paper
• Cannabis Use and the Endocannabinoid System: A Clinical Perspective.

  2022cites this paper
• Chronic cannabis use affects cerebellum dependent visuomotor adaptation.

  2022cites this paper
• The why behind the high: determinants of neurocognition during acute cannabis exposure

  2021cites this paper
• Brain imaging of cannabinoid type I (CB1) receptors in women with cannabis use disorder and male and female healthy controls

  2021cites this paper
• The effects of fatty acid amide hydrolase inhibition and monoacylglycerol lipase inhibition on habit formation in mice

  2021cites this paper
• Functional brain connectomes reflect acute and chronic cannabis use

  2021cites this paper
• Psychedelic experience dose-dependently modulated by cannabis: results of a prospective online survey

  2021cites this paper
• Altered amygdala-cortical connectivity in individuals with Cannabis use disorder

  2021cites this paper
• Acute effects of Δ9-tetrahydrocannabinol and cannabidiol on auditory mismatch negativity

  2021cites this paper
• Progress on the application of positron emission tomography imaging of cannabinoid type 1 receptor in neuropsychiatric diseases.

  2021influential citation
• The acute and non-acute effects of cannabis on reward processing: A systematic review.

  2021cites this paper
• Chlorpyrifos and Δ9 Tetrahydrocannabinol exposure and effects on parameters associated with the endocannabinoid system and risk factors for obesity

  2021cites this paper
• A review of the effects of acute and chronic cannabinoid exposure on the stress response.

  2021cites this paper
• Is resting-state functional connectivity altered in regular cannabis users? A systematic review of the literature

  2021cites this paper
• Allele-dosage genetic polymorphisms of cannabinoid receptor 1 predict attention, but not working memory performance in humans.

  2021cites this paper
• Assessment of transient dopamine responses to smoked cannabis.

  2021cites this paper
• The Alerting and Orienting Systems of Attention Are Modified by Cannabis Dependence

  2021cites this paper
• Cannabis sativa as a Treatment for Obesity: From Anti-Inflammatory Indirect Support to a Promising Metabolic Re-Establishment Target

  2021cites this paper
• Psychosis-relevant effects of intravenous delta-9-tetrahydrocannabinol - A mega analysis of individual participant-data from human laboratory studies.

  2020cites this paper
• Interaction of Cannabis Use and Aging: From Molecule to Mind

  2020influential citation
• Cannabis Use and the Risk for Psychosis and Affective Disorders

  2020cites this paper
• Fatty acid amide hydrolase is lower in young cannabis users

  2020cites this paper
• Blunted highs: Pharmacodynamic and behavioral models of cannabis tolerance.

  2020cites this paper
• Acute and chronic effects of Δ9-tetrahydrocannabinol (THC) on cerebral blood flow: A systematic review.

  2020cites this paper
• 2-Arachidonoylglycerol Modulation of Anxiety and Stress Adaptation: From Grass Roots to Novel Therapeutics.

  2020cites this paper
• Deconstructing the neurobiology of cannabis use disorder

  2020cites this paper
• Cannabis and the Developing Adolescent Brain

  2020cites this paper
• Meet Your Stress Management Professionals: The Endocannabinoids.

  2020cites this paper
• Impact of cannabis on non-medical opioid use and symptoms of posttraumatic stress disorder: a nationwide longitudinal VA study

  2020cites this paper
• PET Imaging of the Endocannabinoid System

  2020cites this paper
• Evidence for the Endocannabinoid System as a Therapeutic Target in the Treatment of Cannabis Use Disorder

  2020cites this paper
• Quantification of the Cannabinoid Type 1 Receptor Availability in the Mouse Brain

  2020cites this paper
• Neurocognitive Disorders in Substance Use Disorders

  2020cites this paper
• Mgll Knockout Mouse Resistance to Diet-Induced Dysmetabolism Is Associated with Altered Gut Microbiota

  2020cites this paper
• Abnormalities of Neurotransmission in Drug Addiction

  2020cites this paper
• Sex differences in the cardiometabolic health of cannabis users with a psychotic illness.

  2019cites this paper
• Is There a Role for GPCR Agonist Radiotracers in PET Neuroimaging?

  2019cites this paper
• Cannabis: From a Plant That Modulates Feeding Behaviors toward Developing Selective Inhibitors of the Peripheral Endocannabinoid System for the Treatment of Obesity and Metabolic Syndrome

  2019cites this paper
• Endocannabinoid signaling in reward and addiction

  2019cites this paper
• In Vivo Imaging of Translocator Protein in Long-term Cannabis Users.

  2019cites this paper
• Cannabinoid interventions for PTSD: Where to next?

  2019cites this paper
• Vaporized Cannabis Extracts Have Reinforcing Properties and Support Conditioned Drug-Seeking Behavior in Rats

  2019cites this paper
• Neurochemical Imaging in Addiction

  2019cites this paper
• Role of the endocannabinoidome in human and mouse atherosclerosis.

  2019cites this paper
• Cerebellar alterations in cannabis users: A systematic review

  2019cites this paper
• Bi‐directional modulation of food habit expression by the endocannabinoid system

  2019cites this paper
• A systematic review of phytocannabinoid exposure on the endocannabinoid system: Implications for psychosis.

  2019cites this paper
• The neuropsychopharmacology of cannabis: A review of human imaging studies

  2019influential citation
• Brain structural changes in cannabis dependence: association with MAGL

  2019cites this paper
• Chronic Cannabis Use and Treatment Failure of Onabotulinum Toxin A for Chronic Migraine

  2019cites this paper
• Reduced responsiveness of the reward system is associated with tolerance to cannabis impairment in chronic users

  2019cites this paper
• Lifestyle and Metabolic Syndrome: Contribution of the Endocannabinoidome

  2019cites this paper
• Reduced responsiveness of the reward system underlies tolerance to cannabis impairment in chronic users

  2019cites this paper
• Acute separate and combined effects of cannabinoid and nicotinic receptor agonists on MMN-indexed auditory deviance detection in healthy humans.

  2019cites this paper
• The Importance of Drug and Sex Effects in Psychiatric Research.

  2018cites this paper
• Cannabis Users Show Enhanced Expression of CB1-5HT2A Receptor Heteromers in Olfactory Neuroepithelium Cells

  2018cites this paper
• Cannabis Users Show Enhanced Expression of CB1-5HT2A Receptor Heteromers in Olfactory Neuroepithelium Cells

  2018cites this paper
• Sweet flowers are slow, and weeds make haste: leveraging methodology from research on tobacco, alcohol, and opioid analgesics to make rapid and policy-relevant advances in cannabis science

  2018cites this paper
• Endocannabinoid signaling in psychiatric disorders: a review of positron emission tomography studies

  2018cites this paper